Jian Xu

Jian Xu

Auto-generated profile, based on publicly available information

Jian Xu

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430022

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2025 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
XWXuezhu Wang
Xuezhu Wang
LZLiping Zuo
Liping Zuo
YYYanying Yu
Yanying Yu
XXXinyi Xiong
Xinyi Xiong
JXJian Xu
Jian Xu
JLJian Li
Jian Li
Plasma cell disorders (PCDs) are marked by the clonal proliferation of abnormal plasma cells and bone marrow plasma cells (BMPCs), causing various clinical complications. These PCDs include subtypes with distinct clinical features. Multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS) are more common and relatively well-studied. In contrast, primary light-chain amyloidosis (AL) and POEMS syndrome (POEMS) are rare and remain less understood. To investigate the role of clonal hematopoietic (CH) mutations and potential interconnections in these diseases, we sequenced CH mutations in lymphoid and myeloid lineages, as well as myeloma driver gene mutations, in BMPCs from affected patients. Recurrent lymphoid CH mutations (in FAT1, KMT2D, MGA, and SYNE1) and myeloma driver gene mutations (in ZFHX3 and DIS3) were found in the dominant clonal and subclonal plasma cell populations. These moderately aging-associated lymphoid CH mutations had a higher burden in MM than in AL or POEMS. Binary matrix factorization of these mutations revealed the subgroups associated with progression-free survival (PFS) (observed in MM, AL, and POEMS), age at diagnosis (in AL and POEMS), serum differential free light chain (dFLC) levels, plasma cell burden (in AL), and serum vascular endothelial growth factor (VEGF) levels (in POEMS). Moreover, the poor PFS associated with MGA or SYNE1 mutations was confirmed across MM, AL, and POEMS. CH mutations partially explained the shared pathogenesis of MM, AL, POEMS, and MGUS, and helped identify patient subgroups with specific clinical features.

21 February 2026 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
WCWeiyu Che
Weiyu Che
JXJian Xu
Jian Xu
YZYamin Zhang
Yamin Zhang